5 Small-Cap Stocks with High Potential

3. Travere Therapeutics, Inc. (NASDAQ:TVTX)

Number of Hedge Fund Holders: 37

Market Capitalization: $718 million

San Diego, California-based Travere Therapeutics, Inc. (NASDAQ:TVTX) is a biopharmaceutical company focused on developing therapies for rare diseases. It has two approved therapies: FILSPARI® (sparsentan) for adults with primary IgA nephropathy, and THIOLA EC® (tiopronin) to help prevent the formation of one type (cystine) of kidney stones.

On September 5, Travere Therapeutics, Inc. (NASDAQ:TVTX) completed the sale of its bile acid product portfolio that includes Cholbam and Chenodal to Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM). The company received $210 million at closing and is eligible for up to $235 million in potential sales-based milestone payments.

Travere Therapeutics, Inc. (NASDAQ:TVTX) ranks #3 on our list of 15 small-cap stocks with high potential based on the number of hedge funds holding its shares as of September 30, 2023. The shares of the company were owned by 37 hedge funds with a total value of $298 million.